KC
| |
Kynam Capital Management, LP13F | |
Kynam Capital Management, LP | |
Last update 2025-05-15 | 32 Stocks (5 new) |
Value $1.19 Bil | Turnover 17 % |
Kynam Capital Management, LP Top Holdings of 2025-03-31
View Full List
Ticker | | Company | Shares | Value ($1000) | Shares Change % | Weighting % | Trade Impact % | % of Shares outstanding | 3M Change % | YTD Change % | Market Cap $Mil | Industry |
---|---|---|---|---|---|---|---|---|---|---|---|---|
NTRA | Natera Inc | 1,167,570 | 165,106.1 | -42.26% | 13.870 | -8.00% | 0.860 | +16.62% | +2.19% | 22,087.8 | Medical Diagnostics & Research | |
PCVX | Vaxcyte Inc | 3,200,000 | 120,832.0 | +36.94% | 10.150 | +2.74% | 2.480 | +8.80% | -59.38% | 4,289.4 | Biotechnology | |
CLDX | Celldex Therapeutics Inc | 6,500,000 | 117,975.0 | +28.35% | 9.910 | +2.19% | 9.790 | +28.28% | -12.94% | 1,460.7 | Biotechnology | |
SNDX | Syndax Pharmaceuticals Inc | 8,520,000 | 104,668.2 | 0% | 8.790 | 0% | 9.900 | -27.77% | -31.92% | 774.4 | Biotechnology | |
BCRX | BioCryst Pharmaceuticals Inc | 8,928,523 | 66,963.9 | -1.73% | 5.630 | -0.07% | 4.270 | +21.96% | +18.88% | 1,870.7 | Drug Manufacturers | |
CGON | CG Oncology Inc | 2,611,662 | 63,959.6 | +3.65% | 5.370 | +0.19% | 3.430 | +43.54% | -6.21% | 2,050.5 | Biotechnology | |
VRDN | Viridian Therapeutics Inc | 4,700,000 | 63,356.0 | +41.30% | 5.320 | +1.55% | 5.760 | +23.87% | -18.26% | 1,278.5 | Biotechnology | |
VERA | Vera Therapeutics Inc | 2,400,000 | 57,648.0 | +64.62% | 4.840 | +1.90% | 3.760 | +5.54% | -43.25% | 1,530.6 | Biotechnology | |
COGT | Cogent Biosciences Inc | 9,105,000 | 54,538.9 | 0% | 4.580 | 0% | 8.000 | +42.21% | -2.82% | 863.0 | Biotechnology | |
IMCR | Immunocore Holdings PLC | 1,695,576 | 50,307.7 | +38.35% | 4.230 | +1.17% | 3.380 | +13.71% | +11.93% | 1,658.7 | Biotechnology |
Kynam Capital Management, LP's Historical Top Holdings Breakdowns
Kynam Capital Management, LP's Top Stock Picks
View Full List
Ticker | | Company | Date | Action | Impact % | Price Range | Price | Price Change from Avrg% | Comment | Current Shares | Share Change |
---|---|---|---|---|---|---|---|---|---|---|---|
NTRA | Natera Inc | 2025-03-31 | Reduce Reduce | -8.00% | 132.63 ($160.74) 177 | $161.76 | 0.63% | Reduce -42.26% | 1,167,570 | -854,528 | |
DVAX | Dynavax Technologies Corp | 2025-03-31 | Reduce Reduce | -2.97% | 12.39 ($13.23) 14.4 | $10.27 | -22.37% | Reduce -60.05% | 2,620,797 | -3,940,038 | |
PCVX | Vaxcyte Inc | 2025-03-31 | Add Add | +2.74% | 37.76 ($79.95) 92.13 | $33.25 | -58.41% | Add 36.94% | 3,200,000 | 863,204 | |
CLDX | Celldex Therapeutics Inc | 2025-03-31 | Add Add | +2.19% | 18.15 ($22.34) 27.6 | $22.00 | -1.52% | Add 28.35% | 6,500,000 | 1,435,793 | |
VERA | Vera Therapeutics Inc | 2025-03-31 | Add Add | +1.90% | 24.02 ($32.13) 43.22 | $24.00 | -25.30% | Add 64.62% | 2,400,000 | 942,090 | |
LEGN | Legend Biotech Corp | 2025-03-31 | New Buy New Buy | +1.74% | 31.43 ($35.86) 39.7 | $35.64 | -0.61% | New holding | 610,000 | 610,000 | |
VRDN | Viridian Therapeutics Inc | 2025-03-31 | Add Add | +1.55% | 13.48 ($17.03) 20.91 | $15.67 | -7.99% | Add 41.3% | 4,700,000 | 1,373,738 | |
TYRA | Tyra Biosciences Inc | 2025-03-31 | Add Add | +1.47% | 9.3 ($12.94) 16.73 | $10.00 | -22.72% | Add 353.57% | 2,406,067 | 1,875,589 | |
BEAM | Beam Therapeutics Inc | 2025-03-31 | Add Add | +1.25% | 19.53 ($26.2) 34.09 | $20.01 | -23.63% | Add 43.39% | 2,518,170 | 762,012 | |
IMCR | Immunocore Holdings PLC | 2025-03-31 | Add Add | +1.17% | 28.21 ($30) 33 | $33.02 | 10.07% | Add 38.35% | 1,695,576 | 470,000 |
Kynam Capital Management, LP Total Holding History ($B)
Kynam Capital Management, LP's Asset Allocation
Kynam Capital Management, LP Past Portfolios
Portfolio Date | Number of Stocks | New Stocks | Total Value ($Mil) | Q/Q Turnover |
---|---|---|---|---|
Top Ranked Articles
- 1
Kynam Capital Management, LP's Hypothetical Growth since 2025-03-31
Kynam Capital Management, LP's Yearly Returns
Year | Portfolio % | % | Excess Gain % |
---|
Kynam Capital Management, LP's Holdings Heat Map
Size field:
Kynam Capital Management, LP's Holdings Bubble Chart
Kynam Capital Management, LP News
- 1